Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 2/20 | 0.48 |
| ▸ | F2 | P00734 | 2/20 | 0.47 |
| ▸ | BACE1 | P56817 | 5/20 | 0.45 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.45 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.44 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18905179 | 0.95 | KISS1R (0.49) | KISS1RF2BACE1BACE2NTSR2 | |
| SCHEMBL18905180 | 0.93 | BACE1 (0.52) | KISS1RBACE1BACE2NTSR2NTSR1 | |
| SCHEMBL11886062 | 0.90 | NPY4R (0.55) | KISS1RF2 | |
| SCHEMBL29539204 | 0.90 | NPY4R (0.55) | KISS1RF2 | |
| SCHEMBL29857796 | 0.90 | NPY4R (0.55) | KISS1RF2 | |
| SCHEMBL29617176 | 0.90 | NPY4R (0.55) | KISS1RF2 | |
| SCHEMBL29972923 | 0.87 | NAALAD2 (0.53) | F2BACE1BACE2NTSR2NTSR1 | |
| SCHEMBL29857400 | 0.87 | ACE (0.51) | KISS1RF2BACE1BACE2OPRD1 | |
| SCHEMBL29458786 | 0.87 | ACE (0.51) | KISS1RF2BACE1BACE2OPRD1 | |
| SCHEMBL11886068 | 0.87 | ACE (0.51) | KISS1RF2BACE1BACE2OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170151146-A1 | HAIR TREATMENT AGENTS | HENKEL AG & CO. KGAA (DE) | 2017-06-01 | — | — | US | disclosed |
| US-20170151163-A1 | HIGH-PERFORMANCE HAIR TREATMENT AGENTS WITH AN ANTI-WASHOUT EFFECT | HENKEL AG & CO. KGAA (DE) | 2017-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170151146-A1 | HAIR TREATMENT AGENTS | OAT, OTC, SLC26A4 | KISS1R 4529/4885F2 4015/4885BACE1 4134/4885 |
| US-20170151163-A1 | HIGH-PERFORMANCE HAIR TREATMENT AGENTS WITH AN ANTI-WASHOUT EFFECT | OAT, CD44, FUT5 | KISS1R 3487/4885F2 4059/4885BACE1 4425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.